UPDATE 3-New Novartis CEO feels heat on U.S. generics business By: Reuters: Company News April 19, 2018 at 05:37 AM EDT * Cosentyx sales miss average analyst forecast (Recasts story to focus on Cosentyx, Sandoz; adds share performance) Read More >> Related Stocks: Amgen Gsk Plc ADR Novan Inc